Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

ETR/FRE stock hub

ETR/FRE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/FREis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

23.1B

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/FRE

In the news

Latest news · ETR/FRE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11.2

P25 12.3P50 15.7P75 20.2

Trailing P/E15.2

P25 16.4P50 20.9P75 30.4

ROE7.8

P25 -6.7P50 8.5P75 17.2

ROIC5.5

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/FRE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

243

Groups with data

Currency

EUR

Showing 243 of 243 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees	178,583
Employees Change	-1,301%
Employees Change Percent	-0.72
Enterprise value	EUR 33.6B
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Medical Care Facilities
Isin	DE0005785604
Last refreshed	2026-05-10
Market cap	EUR 23.1B
Price	EUR 40.96
Price currency	EUR
Rev Per Employee	129,292.45x
Sector	Healthcare
Sic	8090
Symbol	etr/FRE
Website	https://www.fresenius.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.37%
EV Earnings	22.86x
EV/EBIT	13.49x
EV/EBITDA	9.79x
EV/FCF	18.57x
EV/Sales	1.46x
FCF yield	7.84%
Forward P/E	11.16x
P/B ratio	1.13x
P/E ratio	15.24x
P/S ratio	1x
PE Ratio10 Y	19.14x
PE Ratio3 Y	31.35x
PE Ratio5 Y	21.13x
PEG ratio	1.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	9.91%
EBITDA Margin	13.2%
FCF margin	7.87%
Gross margin	25.29%
Gross Profit	EUR 5.8B
Gross Profit Growth	3.14%
Gross Profit Growth Q	8.56%
Gross Profit Growth3 Y	10.95%
Gross Profit Growth5 Y	-10.48%
Net Income	EUR 1.5B
Net Income Growth	248.34%
Net Income Growth Q	89.96%
Net Income Growth Quarters	4%
Net Income Growth Years	2%
Net Income Growth3 Y	4.05%
Net Income Growth5 Y	-2.67%
Pretax Margin	9.36%
Profit Margin	6.4%
Profit Per Employee	EUR 8,269
Profitable Years	2
ROA	3.33
Roa5y	2.54
ROCE	6.94
ROE	7.79
Roe5y	5.81
ROIC	5.53
Roic5y	3.88

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-2.6%
Cagr15y	5.17%
Cagr1y	-2.94%
Cagr20y	6.8%
Cagr3y	19.49%
Cagr5y	1.75%
Div CAGR10	6.68%
Div CAGR3	4.5%
Div CAGR5	-9.4%
EPS Growth	248.3
EPS Growth Q	89.96
EPS Growth Quarters	4
EPS Growth Years	2
EPS Growth3 Y	4.47
EPS Growth5 Y	-2.87
FCF Growth	19.88%
FCF Growth3 Y	-17.53%
FCF Growth5 Y	-15%
OCF Growth	16.23%
OCF Growth Q	594.64%
OCF Growth10 Y	-0.74%
OCF Growth3 Y	-12.04%
OCF Growth5 Y	-14.39%
Revenue Growth	3.03x
Revenue Growth Q	1.98x
Revenue Growth Quarters	8x
Revenue Growth Years	2x
Revenue Growth3 Y	10.43x
Revenue Growth5 Y	-8.65x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.54
Assets	EUR 42.4B
Cash	EUR 2.1B
Current Assets	EUR 12.1B
Current Liabilities	EUR 9.5B
Debt	EUR 11.9B
Debt EBITDA	EUR 3.7
Debt Equity	EUR 0.58
Debt FCF	EUR 6.58
Equity	EUR 20.5B
Interest Coverage	5.25
Liabilities	EUR 21.9B
Long Term Assets	EUR 30.3B
Long Term Liabilities	EUR 12.4B
Net Cash	EUR -9.8B
Net Cash By Market Cap	EUR -42.68
Net Debt EBITDA	EUR 3.25
Net Debt Equity	EUR 0.48
Net Debt FCF	EUR 5.44
Tangible Book Value	EUR 3B
Tangible Book Value Per Share	EUR 5.36
WACC	6.84

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.27
Inventory Turnover	6.4
Net Working Capital	EUR 2.8B
Quick ratio	0.65
Working Capital	EUR 2.5B
Working Capital Turnover	EUR 7.53

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	5%
Dividend Growth Years	1%
Dividend per share	EUR 1.05
Dividend Years	2
Dividend Yield	2.56%
Ex Div Date	2026-05-25
Last Dividend	EUR 1.05
Payout Ratio	31.77%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-23.14%
1Y total return	-2.94%
200-day SMA	46.82
3Y total return	70.64%
50-day SMA	44.58
50-day SMA vs 200-day SMA	50under200
5Y total return	9.07%
All Time High	80.07
All Time High Change	-48.84%
All Time High Date	2017-06-20
All Time Low	1.04
All Time Low Change	3,823.37%
All Time Low Date	1993-01-12
ATR	1.14
Beta	0.86
Beta1y	1.11
Beta2y	0.8
Ch YTD	-16.37
High	41.8
High52	52.96
High52 Date	2026-02-19
High52ch	-22.66%
Low	40.5
Low52	38.18
Low52 Date	2026-05-06
Low52ch	7.28%
Ma50ch	-8.12%
Price vs 200-day SMA	-12.51%
RSI	40.12
RSI Monthly	50.56
RSI Weekly	35.72
Sharpe ratio	-0.21x
Sortino ratio	-0.03
Total Return	2.56%
Tr YTD	-16.37
Tr15y	113.07%
Tr1m	-5.19%
Tr1w	0.37%
Tr3m	-17.68%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 2.3B
Operating Income Growth	9.43
Operating Income Growth Q	-2.94
Operating Income Growth3 Y	16.28
Operating Income Growth5 Y	-11.98
Operating margin	9.91

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	410,557,768%
Net Borrowing	-1,809,000,000
Shares Institutions	40.67%
Shares Out	563,237,277
Shares Qo Q	-1.71%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 1.8B
Average Volume	1,252,305.7x
Bv Per Share	35.12
CAPEX	EUR -1.1B
Ch10y	-35.11
Ch15y	70.33
Ch1m	-5.19
Ch1w	0.37
Ch1y	-5.19
Ch20y	178.8
Ch3m	-17.68
Ch3y	61.13
Ch5y	-1.69
Ch6m	-14.02
Change	0.54%
Change From Open	0.91
Close	40.74
Days Gap	-0.37
Depreciation Amortization	755,000,000
Dollar Volume	61,945,405.4
Earnings Date	2026-05-06
EBIT	EUR 2.3B
EBITDA	EUR 3B
EPS	EUR 2.61
F Score	7
FCF	EUR 1.8B
FCF EV Yield	5.38x
FCF Per Share	EUR 3.21
Financing CF	-2,404,000,000
Fiscal Year End	December
Founded	1,912
Goodwill	14,619,000,000
Graham Number	46.19175
Graham Upside	12.77
Income Tax	EUR 573M
Investing CF	-845,000,000
Is Primary Listing	1
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Date	2014-08-04
Last Split Type	Forward
Lynch Fair Value	EUR 13.05
Lynch Upside	-68.14
Ma150	47.27
Ma150ch	-13.35%
Ma20	42.14
Ma20ch	-2.81%
Net CF	-328,000,000
Next Earnings Date	2026-08-05
Open	40.59
P FCF Ratio	12.75
P OCF Ratio	7.94
Payment Date	2026-05-27
Position In Range	35.38
Ppne	9,729,000,000
Price Date	2026-05-08
Price EBITDA	EUR 7.61
Ptbv Ratio	7.64
Relative Volume	1.24x
Revenue	22,986,000,000x
Tax By Revenue	2.49x
Tax Rate	26.64%
Tr20y	272.88%
Tr6m	-14.02%
Volume	1,512,339
Z Score	2

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

ETR/FRE dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.6%

$1.05 annual per share

Payout ratio

+31.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-9.4%

1 consecutive years of growth

Total shareholder yield

+2.6%

Next ex-dividend date: 2026-05-25

Performance

ETR/FRE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/FRE?

Insider, institutional, and short-interest positioning.

Institutional ownership

+40.7%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

ETR/FRE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.1

Neutral momentum band

Price vs 200-day MA

-12.5%

50/200-day relationship not available

Beta (5Y)

0.86

Moves roughly with the market

Sharpe ratio

-0.21

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/FRE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/FRE stock rating?

etr/FRE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/FRE analysis?

The full report lives at /stocks/etr/FRE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/FRE?

The latest report frames etr/FRE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/FRE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.